Remission of Primary Hyperparathyroidism Following Fine-Needle Aspiration Biopsy: A Case Report and Review of the Literature.

FNAB, fine-needle aspiration biopsy PHPT PHPT, primary hyperparathyroidism PTH, parathyroid hormone US, ultrasonography fine-needle aspiration biopsy primary hyperparathyroidism remission

Journal

AACE clinical case reports
ISSN: 2376-0605
Titre abrégé: AACE Clin Case Rep
Pays: United States
ID NLM: 101670593

Informations de publication

Date de publication:
Historique:
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 15 4 2021
Statut: epublish

Résumé

Spontaneous or fine-needle aspiration biopsy (FNAB)-induced remission of primary hyperparathyroidism (PHPT) is an extremely rare and generally transient phenomenon. A 40-year-old woman with a history of recurrent kidney stones was diagnosed with PHPT (serum calcium, 14.2 mg/dL; parathyroid hormone [PTH], 380 pg/mL). Ultrasonography and scintigraphy findings were consistent with a left enlarged parathyroid. Ultrasound-guided-FNAB cytology of the lesion did not confirm a parathyroid nature. However, levels of PTH within the needle-washing fluid were elevated. After few days, there was evidence of biochemical remission of the hypercalcemia (calcium, 8.1 mg/dL), and at subsequent follow-up visits, the enlarged parathyroid showed progressive shrinkage with eucalcemia and normalized PTH levels throughout 12 months of follow-up. Rarely, remission of PHPT may occur after ultrasound-guided-FNAB performed on a hyperfunctioning parathyroid lesion.

Sections du résumé

BACKGROUND BACKGROUND
Spontaneous or fine-needle aspiration biopsy (FNAB)-induced remission of primary hyperparathyroidism (PHPT) is an extremely rare and generally transient phenomenon.
METHODS METHODS
A 40-year-old woman with a history of recurrent kidney stones was diagnosed with PHPT (serum calcium, 14.2 mg/dL; parathyroid hormone [PTH], 380 pg/mL). Ultrasonography and scintigraphy findings were consistent with a left enlarged parathyroid. Ultrasound-guided-FNAB cytology of the lesion did not confirm a parathyroid nature. However, levels of PTH within the needle-washing fluid were elevated.
RESULTS RESULTS
After few days, there was evidence of biochemical remission of the hypercalcemia (calcium, 8.1 mg/dL), and at subsequent follow-up visits, the enlarged parathyroid showed progressive shrinkage with eucalcemia and normalized PTH levels throughout 12 months of follow-up.
CONCLUSIONS CONCLUSIONS
Rarely, remission of PHPT may occur after ultrasound-guided-FNAB performed on a hyperfunctioning parathyroid lesion.

Identifiants

pubmed: 33851026
doi: 10.1016/j.aace.2020.11.021
pii: S2376-0605(20)31022-1
pmc: PMC7924148
doi:

Types de publication

Case Reports

Langues

eng

Pagination

75-79

Informations de copyright

© 2020 AACE. Published by Elsevier Inc.

Références

J Endocrinol Invest. 2004 Jul-Aug;27(7):687-90
pubmed: 15505996
AJR Am J Roentgenol. 2012 Nov;199(5):1164-8
pubmed: 23096194
Endocr Relat Cancer. 2019 Jul;26(7):R441-R464
pubmed: 31085770
J Clin Endocrinol Metab. 2015 Jan;100(1):E87-90
pubmed: 25337928
Endocr Pract. 2008 Jan-Feb;14(1):80-6
pubmed: 18238745
Thyroid. 2011 Jul;21(7):805-8
pubmed: 21615303
J Clin Pathol. 2006 Oct;59(10):1094-6
pubmed: 17021134
Endocrinol Diabetes Metab Case Rep. 2019 May 7;2019:
pubmed: 31063971
Head Neck. 2002 Feb;24(2):157-64
pubmed: 11891946
N Engl J Med. 2011 Dec 22;365(25):2389-97
pubmed: 22187986
Endocr Pract. 2020 Mar;26(3):357-358
pubmed: 32163312
J Clin Endocrinol Metab. 1996 Apr;81(4):1326-8
pubmed: 8636326
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
pubmed: 25162665
Eur Radiol. 2014 Sep;24(9):2052-8
pubmed: 24895038
Endocrinol Diabetes Metab Case Rep. 2017 Nov 24;2017:
pubmed: 29204278
Arch Surg. 1975 Aug;110(8):1004-7
pubmed: 1156145
Thyroid. 2007 Dec;17(12):1251-5
pubmed: 17887929

Auteurs

Pierpaolo Falcetta (P)

Department of Clinical and Experimental Medicine, Section of Endocrinology, University Hospital of Pisa, Pisa, Italy.

Filomena Cetani (F)

Endocrinology Unit 2, University Hospital of Pisa, Pisa, Italy.

Massimo Tonacchera (M)

Department of Clinical and Experimental Medicine, Section of Endocrinology, University Hospital of Pisa, Pisa, Italy.

Classifications MeSH